hypokalemia causing drugs
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Finding Sources
Searching the Web
drugs causing hypokalemia mechanism list clinical pharmacology
I have comprehensive data from the textbooks. Let me compile a thorough, well-organized answer.
Here is a comprehensive breakdown of drugs that cause hypokalemia, organized by mechanism:
Drugs Causing Hypokalemia
Hypokalemia (serum K+ < 3.5 mEq/L) is caused by drugs through three main mechanisms: transcellular shift (K+ moves into cells), increased renal loss, and increased GI loss.
1. Transcellular Shift (K+ Moved Into Cells)
These drugs lower serum K+ by redistributing it intracellularly without true total-body depletion.
| Drug / Class | Mechanism |
|---|---|
| Insulin | Activates Na+/K+-ATPase, driving K+ into skeletal muscle and liver cells |
| Beta-2 adrenergic agonists (salbutamol, terbutaline, salmeterol, epinephrine) | Stimulate β2 receptors → activate Na+/K+-ATPase → K+ uptake into muscle and liver |
| Theophylline / Aminophylline | Catecholamine release + direct β2 stimulation |
| Vitamin B12 / Folic acid (in megaloblastic anemia treatment) | Rapid cell proliferation consumes K+ as new red blood cells and platelets are formed |
| Barium salts (accidental ingestion) | Block K+ efflux channels in cells, trapping K+ intracellularly |
- Morgan and Mikhail's Clinical Anesthesiology, 7e, p. 2912
2. Increased Renal Loss
This is the most common drug-induced mechanism.
A. Diuretics (most common cause overall)
| Drug | Class | Mechanism |
|---|---|---|
| Furosemide, bumetanide, torsemide, ethacrynic acid | Loop diuretics | Block Na-K-2Cl cotransporter in the thick ascending loop of Henle → increased distal tubule flow → enhanced K+ secretion via ROMK and BK channels; also stimulate aldosterone and AVP release |
| Hydrochlorothiazide, chlorthalidone, metolazone | Thiazide diuretics | Block NaCl cotransporter in the DCT → same four mechanisms: ↑ flow, ↑ AVP, ↑ aldosterone, alkalosis |
| Acetazolamide | Carbonic anhydrase inhibitor | Causes renal tubular acidosis (proximal) + bicarbonaturia → increased Na+ delivery to collecting duct → kaliuresis |
| Mannitol | Osmotic diuretic | Osmotic diuresis increases distal tubule flow → K+ secretion |
- Brenner and Rector's The Kidney, p. 2281 (Fig. 50.20 details four mechanisms of diuretic-induced hypokalemia)
B. Antibiotics
| Drug | Mechanism |
|---|---|
| Amphotericin B | Creates pores in the tubular cell membrane → direct renal K+ wasting; also causes distal renal tubular acidosis |
| Gentamicin (and other aminoglycosides) | Tubular toxicity → renal K+ and Mg2+ wasting (hypomagnesemia then worsens hypokalemia) |
| Carbenicillin (and high-dose penicillins) | Non-reabsorbable anion in tubular lumen → obligates K+ secretion to maintain electrochemical neutrality |
- Morgan and Mikhail's Clinical Anesthesiology, 7e, p. 2906-2907
C. Mineralocorticoid / Glucocorticoid Excess (drug-induced)
| Drug | Mechanism |
|---|---|
| Fludrocortisone | Direct mineralocorticoid effect → stimulates ENaC and H+/K+-ATPase → increased K+ secretion |
| Hydrocortisone, prednisone, dexamethasone (high dose) | Glucocorticoids have mild mineralocorticoid activity → renal K+ wasting |
| Licorice / Carbenoxolone | Inhibit 11β-hydroxysteroid dehydrogenase type 2 → cortisol acts on mineralocorticoid receptors → apparent mineralocorticoid excess |
D. Other Renal-Loss Drugs
| Drug | Mechanism |
|---|---|
| Cisplatin / Carboplatin | Nephrotoxicity → renal Mg2+ and K+ wasting; hypomagnesemia secondarily causes refractory hypokalemia |
| Ifosfamide, tenofovir, aristolochic acid | Fanconi syndrome (proximal tubule dysfunction) → renal K+ wasting |
| Foscarnet | Direct tubular toxicity |
| Insulin (large doses in DKA) | Also promotes renal K+ retention paradoxically while causing a transcellular shift |
- Brenner and Rector's The Kidney, p. 2272 (Fanconi syndrome drugs)
3. Increased GI Loss
| Drug | Mechanism |
|---|---|
| Laxatives (stimulant/osmotic: bisacodyl, senna, sodium phosphate) | Diarrhea → colonic K+ secretion is high (aldosterone-driven in the colon) |
| Magnesium-containing antacids / Mg2+ sulfate | Osmotic diarrhea |
| Sodium polystyrene sulfonate | Ion exchange resin causes GI K+ loss |
4. Secondary Hypokalemia via Hypomagnesemia
Several drugs cause hypomagnesemia, which then causes refractory hypokalemia that cannot be corrected until Mg2+ is replaced:
- Loop and thiazide diuretics (block Mg2+ reabsorption in TAL/DCT)
- Aminoglycosides (gentamicin, tobramycin)
- Cisplatin
- Amphotericin B
- Proton pump inhibitors (omeprazole, pantoprazole) - with prolonged use
The mechanism: Mg2+ depletion releases inhibition of ROMK channels in the distal nephron, causing inappropriate K+ secretion.
- Brenner and Rector's The Kidney, p. 2282
Quick Reference Summary Table
| Mechanism | Key Drugs |
|---|---|
| Transcellular shift | Insulin, β2-agonists, theophylline, B12/folate |
| Loop diuresis | Furosemide, bumetanide, ethacrynic acid |
| Thiazide diuresis | HCTZ, chlorthalidone, metolazone |
| Antibiotic-renal loss | Amphotericin B, gentamicin, carbenicillin |
| Mineralocorticoid effect | Fludrocortisone, steroids, licorice/carbenoxolone |
| Fanconi syndrome | Cisplatin, ifosfamide, tenofovir |
| GI loss | Laxatives, Mg-containing antacids |
| Via hypomagnesemia | Cisplatin, aminoglycosides, PPIs, loop/thiazide diuretics |
Clinical pearl: When hypokalemia is refractory to K+ replacement, always check serum Mg2+ - hypomagnesemia must be corrected first, as Mg2+ depletion sustains renal K+ wasting regardless of supplementation. - Brenner and Rector's The Kidney, p. 2282
This is a shared conversation. Sign in to Orris to start your own chat.